Remove Communication Remove Packaging Remove Workshop
article thumbnail

NABP Pilot Brings Trading Partners, Regulators Together for Public Health Protection

National Association of Boards of Pharmacy

We’ve been working with the boards of pharmacy, other regulators, and trading partners to prepare for the requirements included in Title II of the Act, which calls for product tracing at the package level. The primary goals of this project? The network is expected to: Be consistent with the Uniform National Policy (Sec.

article thumbnail

Disrupted medical conferences: 2022 and beyond

pharmaphorum

Moreover, no attendee data was available for physical symposia, whereas all virtual symposia packages provided full attendee metrics analyses. Since then, many societies have indeed made discernible progress towards digital transformation of their events and communications practices. Pre-learning and discussion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Metaverse or Virtual Reality? What is the Difference?

Pulses

Table 1: Virtual Technology Platform: Pros and Cons Pros AR VR MR XR Metaverse Enhanced user experience/interaction √ √ Immersive and Engaging Experience √ √ Increased Collaboration and Communication √ √ √ Social interaction √ √ √ √ √ Used in training and simulation √ √ √ √ Enhanced Connectivity √ Creative Expression √ Cons Cybersickness AR VR MR XR (..)

article thumbnail

Potential and Challenges of the APAC Pharmaceutical Industry

Viseven

At the 13 th Korea International Pharmaceutical & Bio-Pharma Exhibition on April 18-21, attendees participated in over 100 seminars, conferences, and workshops. “I We have some arrangements we’ll be able to disclose soon,” says Dodie Guadines, Viseven APAC Regional Director.

article thumbnail

Assumptions to evidence: How NINR project is solidifying UK’s remote trial know how

pharmaphorum

Through a series of workshops and surveys, which collected the views of research professionals, patients and carers, the group has developed a new guidance document. But how do we package that up?” But we need to evaluate for the gains we hope for, as well as for any unintended consequences.”. A practical consensus.